Multidrug resistance mechanisms in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 116, Issue 4, 2002, Pages 774-780

  Consoli, Ugo ^a,b   Santonocito, Anna Maria ^a   Stagno, Fabio ^a   Fiumara, Paolo ^a   Privitera, Antonella ^a   Parisi, Giuseppina ^a   Giustolisi, Giada M ^a   Pavone, Biagia ^a   Palumbo, Giuseppe A ^a   Di Raimondo, Francesco ^a   Milone, Giuseppe ^a   Guglielmo, Patrizia ^a   Giustolisi, Rosario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Ospedale Ferrarotto   (Italy)

Author keywords

Chronic lymphocytic leukaemia; Multidrug resistance

Indexed keywords

CD19 ANTIGEN; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PROTEIN BCL 2;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTIGENS, CD19; DRUG RESISTANCE, MULTIPLE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTES; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0036121001     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2002.03344.x     Document Type: Article

References (34)

1. High mdr-1 and mrp, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemia
2. High mdr-1 and mrp but low topoisomerase II alpha gene expression in B-cell chronic lymphocytic leukemias
3. Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors: Consensus recommendations
4. High expression of the multi-drug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemias
5. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias
6. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-Sponsored working group
7. The novel anthracycline annamycin is not affected by p-glycoprotein-related multidrug resistance: Comparison with idarubicin and doxorubicin in HL-60 leukemic cell lines
8. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia
9. Expression of a multidrug-resistance gene in human malignant lymphoma and related disorders
10. Involvement of p-glycoprotein in the transmembrane transport of interleukin-2, interleukin-4 and interferon-γ in normal human T lymphocytes
11. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistance tumor cells by monoclonal antibodies
12. Biochemistry of multidrug resistance mediated by the multidrug transporter
13. Structural model of ATP-binding protein associated with cystic fibrosis, multidrug resistance and bacterial transport
14. Overlapping phenotypes of multidrug resistance among panels of human cancer cell lines
15. Quantitation of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: Relevance for the study of B-cell neoplasias
16. Frequency and clinical significance of the expression of the multidrug MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia
17. Double knockout of the MRP gene leads to increased drug sensitivity in vitro
18. Multidrug resistance in leukemia
19. A new human T cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia
20. The expression of the multidrug-associated glycoprotein in B-cell chronic lymphocytic leukemia
21. Correlation of p-glycoprotein expression and function in childhood acute leukemia: A children's cancer group study
22. Clinical staging of chronic lymphocytic leukemia
23. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance
24. Drug resistance mechanisms in chronic lymphocytic leukemia
25. The drug resistance-related protein LRP is the human major vault protein
26. Over-expression of a Mr 110,000 vesicular protein in non-p-glycoprotein-mediated multidrug resistance
27. Functional multidrug resistance phenotype associated with combined overexpression of P-gp/MDR1 and MRP together predict clinical response in acute myeloid leukemia
28. Analysis of multidrug resistance gene expression in chronic lymphatic leukaemia
29. Common expression of the multidrug resistance marker p-gly-coprotein in B-cell chronic lymphatic leukemia and correlation with in-vitro drug resistance
30. Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity
31. Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukaemia
32. MDR1 gene expression in chronic lymphocytic leukemia
33. MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders
34. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia detected by immunofluorescence and northern blot analysis